E N D
The U.S. genetic testing market is projected to grow from $4.38 billion in 2020 to $10.29 billion by 2027, with a CAGR of 13.0%. The market analysis covers several key segments: Key Market Segments: Techniques: DNA sequencing, PCR, microarrays Applications: Oncology, cardiology, pharmacogenomics, cognitive dysfunction Payers: Public/private health insurance, out-of-pocket End Users: Hospitals, independent laboratories Major Growth Drivers: Strong demand for early and preventive care Increased awareness among healthcare professionals Favorable reimbursement policies from insurers Key Challenges: Data privacy concerns around genetic information COVID-19 impact led to cancellation of non-essential diagnostics Limited adoption in some healthcare settings Leading Companies: Quest Diagnostics Myriad Genetics Invitae Corporation Ambry Genetics BioReference Laboratories The report includes detailed analysis of market dynamics, competitive landscape, regulatory overview, and impact of COVID-19 on the genetic testing industry through 2027. Report- Fortune Business Insights - U.S. Genetic Testing Market Size, Trend, Share, Forecast, 2027 https://www.fortunebusinessinsights.com/u-s-genetic-testing-market-105034